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Open-ﬁeldAlthough cocaine induces several behavioral and hormonal effects, little is known about non-contingent re-
peated administrations in non-human primates. Therefore, we analyzed behavioral (locomotion, vigilance)
and hormonal (cortisol) responses of adult black tufted-ear marmosets during repeated administrations
and withdrawal trials. The subjects were divided into two groups (saline or cocaine 5 mg/kg, ip) and submit-
ted to nine treatment trials and four withdrawal trials in the absence of any treatment in an open-ﬁeld arena.
Blood samples were obtained on ﬁve different time points of the procedure to evaluate the effects of repeated
cocaine treatment on basal cortisol levels. Cocaine repeatedly administered to drug-naïve marmosets in-
duced a slow-onset hypervigilance effect (i.e., scan — long-lasting sweeping movements of the head directed
at the environment; and glance — single rapid movement of the head directed at the environment), with no
concomitant change in locomotion. Treatment cessation during withdrawal immediately reversed the
cocaine-induced hypervigilance effect. Cortisol levels remained constant throughout the procedure. There-
fore, marmosets seem to have a similar behavioral — but not hormonal — response as humans and other
nonhuman primates repeatedly injected with cocaine, but differ from rats in their absence of hyperlocomotor
activity. The development of hypervigilance with repeated application may constitute a unique measure to
assess cocaine-induced changes in behavior in the marmoset and other nonhuman primates.
© 2012 Elsevier Inc. Open access under the Elsevier OA license.1. Introduction
Psychostimulants, such as cocaine, induce several behavioral
and hormonal effects in rodents, nonhuman primates (NHP) and
humans. They typically enhance locomotion in rodents, whereas in-
creases in stereotyped psychotomimetic or hallucinatory-like be-
haviors have been reported in NHP and humans (Bradberry, 2007;
Castner and Williams, 2007; Leyton, 2007). In NHP “checking of
the environment” has been reported, although stereotyped grooming,
oral movements (e.g., oralbuccal dyskinesias, vacuous chewing) and
manipulation of objects, as well as the tracking and/or grasping of non-
existent stimuli may also occur (e.g., Farfel et al., 1992; Ridley et al.,
1982). Direct dopaminergic agonists repeatedly injected in monkeys re-
sult in similar behavioral patterns (Kleven andWoolverton, 1990). Sever-
al of these behavioral changes are observed regardless of whether thetical Sciences, School of Health
a, DF, Brazil. Tel./fax: +55 61
vier OA license.drug is applied by contingent (self-administered) or noncontingent
(experimenter-administered) means (Steketee and Kalivas, 2011).
Acute cocaine administration also activates the hypothalamic–
pituitary–adrenal (HPA) axis, leading to an increased release of corti-
costerone in rodents (Mello and Mendelson, 2002) and cortisol in
NHP (Sarnyai et al., 1996) and humans (Baumann et al., 1995).Whether
the release is more pronounced after contingent than noncontingent
administration remains a controversial issue (e.g., Palamarchouk et al.,
2009). Nonetheless, activation of the HPA axis has been associated
to the neural mechanisms of cocaine reinforcement and relapse
(Marinelli and Piazza, 2002). The hormonal effects of repeated cocaine
exposures and withdrawal in NHP have not been addressed.
Due to considerable differences between rodents and primates,
including the morphological organization, connectivity and prenatal
development of the mesocortical DA system (Berger et al., 1991;
Haber and McFarland, 1999; Joel and Weiner, 2000), the dynamics
of dopamine release and uptake in the striatum (Cragg et al., 2000),
the genetic homology of the dopamine transporter (Miller et al., 2001),
the density and distribution of receptors within addiction-related neural
circuits (e.g., Camps et al., 1990) and brain metabolic responses to
psychostimulants (e.g., Lyons et al., 1996), NHP may help bridge
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particularly the small neotropical marmoset monkey (Maior et al.,
2011). However, little is still known about the behavioral and hor-
monal effects of repeated cocaine administrations in this NHP.
Therefore, in the present studywe analyzed locomotor and vigilance-
related behaviors of adult black tufted-ear marmosets during repeated
systemic cocaine administrations andwithdrawal trials. The levels of cir-
culating cortisol were also measured during ﬁve different time points
over the course of the experimental trials to evaluate the effects of
repeated cocaine treatment on basal cortisol levels.
2. Methods
2.1. Subjects and housing conditions
We used 10, experimentally-naïve, adult black tufted-ear marmosets
(Callithrix penicillata), weighing 290–410 g at the beginning of the study.
They were housed in pairs at the Primate Center of the University of
Brasilia in cages (2×1.3×2 m each) of a same colony room. This room,
which consisted of twoparallel rows of 12 cages, separated by a common
wire-mesh enclosed central corridor, formed an outdoor/semi-indoor
housing system; thus, themarmosetswere exposed to natural light, tem-
perature and humidity conditions. Each home-cage consisted of twopar-
allel concrete walls (separating adjacent cages), a wire-mesh front, back
and top, a suspended wooden nest-box, several wooden perches at dif-
ferent heights, a food tray (where food bowl was placed), a PVC feeding
tube (for dry food pellets) hung from the wire mesh top, and a layer of
saw dust on the ﬂoor. Additionally, a solid roof 50–150 cm above the
wire-mesh top covered two thirds of all cages. Food was provided
twice a day, at 07:00 h and 13:00 h, consisting of amixture of fresh fruits
and vegetables, with meal-worms, boiled eggs, various nuts and/or
cooked chicken breast given three times aweek.Water and dry food pel-
lets were available ad libitum. Housing conditions complied with the
regulations of the Brazilian Institute of Environment and Renewable Nat-
ural Resources (IBAMA). All procedures employedwere approved by the
Animal Ethics Committee of the University of Brasilia, complied with the
‘Brazilian Principles of Laboratory Animal Use’ (COBEA) and followed the
NIH guidelines for care and use of laboratory animals.
2.2. Drugs
Cocaine hydrochloride (0 and 5 mg/kg; Sigma-Aldrich, USA) was
dissolved in phosphate buffered saline and injected intraperitoneally,
in a volume of 1.0 mL/kg, 5 min prior to the behavioral testing.
2.3. Apparatus
Testing was conducted in a rectangular open-ﬁeld (OF) arena
(130×75×40 cm) suspended 1.2 m from the ﬂoor. Three of its walls
were made of aluminum, whereas the fourth was of 4 mm transparent
glass. This glass wall made up one of the twowidest sides of the rectan-
gular arena (i.e., 130×40 cm). The top consisted glass and the bottom
was made of 2.5 cm2 wire-mesh. The apparatus had a guillotine-type
door located on the wall directly opposite the one made of glass,
which served as its entry/exit point. With the exception of the glass
wall and top, theOF arenawas paintedwhite to enhance the automated
video-tracking of the marmosets.
The apparatus was set up in a test-room located in a building
50 m away from the callitrichid colony facility. The marmosets were
transported to and from the test-room in a covered aluminum
transportation-cage (35×20×23 cm) containing a guillotine-type
door. Two 100 W light bulbs, ﬁxed on opposite walls of the test-
room, acted as a light source. The OF arena was monitored via a
closed-circuit system using two digital cameras (Fire-i, Unibrain,
USA), one mounted approximately 1.5 m directly above the apparatus
(top-view) and one located 1.5 m away from its glass wall (side-view).Both cameras were connected to a PC laptop located outside the test-
room, fromwhere all trials were observed and recorded. Themarmosets
were tracked automatically (via top-view camera) using the AnyMaze
software (Stoelting Co., USA). An observer, using the side-view camera,
manually scored speciﬁc behaviors that could not be automatically distin-
guishedby the software. Also, for the behavioral analyses (see below), the
same software divided the OF arena into 15 square sections of equal
dimensions (26×25×40 cm).
2.4. Behavioral procedure and analyses
The marmosets were randomly assigned to one of two treatment
groups: saline (n=5) or cocaine (n=5). All subjects were initially sub-
mitted to nine 15-min test trials and then to four 15-min withdrawal
trials. All trials were held at 48 h intervals. Each trial consisted in cap-
turing the subject in its home-cage and administering either cocaine
or saline. The marmoset was then placed into the transportation-cage,
taken to the test-room and released into the OF arena after a 5 min in-
terval. At the end of the 15 min trial, the subject was promptly returned
to its home-cage. As no treatment was administered prior to the four
withdrawal trials, the marmosets were taken directly to the OF arena
in the transportation-cage. The order in which subjects were tested
was randomly assigned on each day and the sessions were held be-
tween 13:30 and 17:00 h.
The AnyMaze software (Stoelting Co., USA) automatically tracked the
marmosets’ entry into each of the virtual 15 sections of the OF arena, as
well as the distance and average speed traveled within the apparatus. In
addition, an experienced observer (with a 95% intra-rater reliability)
scored, with the same program, the following vigilance-related behav-
iors by pressing keys on the keyboard upon occurrence of the appropri-
ate response: (1) Leg stand, the frequency of raising the body into a
bipedal position; (2) Glance, the frequency of a single rapid upward or
downward movement of the head directed at the environment, while
the animal remained stationary; and (3) Scan, the frequency and dura-
tion of long-lasting (>5 s) sweeping upward or downward movements
of the head directed at the environment, while the animal remained
stationary. Vigilance behaviors were based on marmoset ethograms
(Stevenson and Poole, 1976; Stevenson and Rylands, 1988) and pre-
vious reports in this species (Barros et al., 2004a, 2004b, 2008).
2.5. Blood sampling and cortisol assay
Five blood samples were obtained from each marmoset as follows:
the ﬁrst sample was taken one week prior to the test-trials (baseline),
the second sample after test-trial 1, the third sample after test-trial 4,
the fourth sample after the last withdrawal-trial and the ﬁfth sample
was taken 12 weeks later. All sampling were done between 09:00 and
11:00 h. Thus, except for the initial baseline sample, blood was taken
the morning after the behavioral trials as to evaluate the effects of
repeated cocaine treatment on basal cortisol levels.
For each blood sampling, themarmoset was captured in its home-
cage and conveyed to an adjacent procedure room where it was
anesthetized with isoﬂurane via inhalation. A 1.0 mL blood sample
was then collected via femoral venipuncture and immediately placed
into a tube containing a gel barrier and clot-promoting additives for
total serum analyses. Following its recovery (b5 min), the subject
was released back into its home-cage, monitored for 15 min and
given vitamin supplements. The sampling procedure (i.e., time elapsed
between entering the home-cage to capture the animal and the end of
the venipuncture) was determined, as this may possibly inﬂuence
the hormone content observed. On average, the latency was 4.02±
0.59 min (mean±SEM), an interval previously reported not to exert a
signiﬁcant inﬂuence on cortisol assays in marmosets (Saltzman et al.,
1994). All procedures were conducted in the presence of the Primate
Center's veterinarian.
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Fig. 1. Mean (±SEM) scan duration (in seconds), as well as the number of scans,
glances and leg stands observed in the saline and cocaine-treated marmosets during
each of the nine administrations and four withdrawal trials. n=5/group; *pb0.05 co-
caine vs. saline; #pb0.05 vs. cocaine test trial 1.
Table 1
Locomotor parameters in the saline and cocaine-treated marmosets during the nine
test and four withdrawal trials.
Distance traveleda Sections crossed Average speedb
Saline Cocaine Saline Cocaine Saline Cocaine
Test trials
1 75±16 90±21 316±62 432±92 0.11±0.04 0.12±0.02
2 60±20 95±42 279±62 480±158 0.07±0.02 0.11±0.05
3 56±25 86±47 248±91 383±157 0.06±0.03 0.12±0.04
4 53±19 58±18 245±66 343±79 0.09±0.05 0.09±0.02
5 60±18 81±38 298±72 442±107 0.07±0.02 0.09±0.04
6 50±21 72±24 254±71 436±109 0.06±0.02 0.08±0.03
7 65±26 64±17 281±96 367±77 0.07±0.03 0.07±0.02
8 62±15 45±21 341±96 261±86 0.08±0.02 0.05±0.02
9 53±12 29±12 275±85 199±61 0.08±0.02 0.03±0.01
Withdrawal trials
1 33±18 57±17 164±65 257±54 0.04±0.02 0.06±0.02
2 50±16 33±8 219±66 176±39 0.06±0.02 0.04±0.01
3 54±11 28±7 298±52 205±49 0.08±0.01 0.03±0.01
4 74±21 49±21 303±81 186±51 0.06±0.03 0.09±0.02
a In meters.
b In meters/second (mean±SEM).
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3.500 rpm and 4 °C. The resulting serum from each sample was
transferred to an Eppendorf vial and diluted to 1:50 with tri-distilled
water for cortisol assay. Dilution factor was based on previous studies
in this species using a similar blood sampling and analysis procedure
(Lima et al., 2008). The diluted serum was then analyzed by single
enzyme-linked-ﬂuorescent assay (ELFA) using commercial cortisol
kits for the automated MiniVidas® immunoassay system (CORS kits;
BioMérieux, USA). Cortisol assay sensitivity was 2 ng/mL and inter-
and intra-assay coefﬁcients of variation (CVs) from pooled serum were
9.6% and 8.2%, respectively.
2.6. Statistical analysis
Behavioralmeasures and cortisol concentrationswere compared for
possible between- and within-group effects. Accordingly, data from
each parameter were analyzed using a mixed design two-way analysis
of variance (ANOVA), with group (cocaine and saline) as the indepen-
dent factor and behavioral trial (test trials 1–9, withdrawal trials 1–4)
or blood sample (1–5) as the repeatedmeasure variable.Whenever sig-
niﬁcant, subsequent comparisons were performed using the appropri-
ate error variance terms from the respective ANOVA summary tables
with Dunnett's test (behavioral data: saline or test trial 1) or Tukey's
test for multiple pair-wise comparisons (cortisol data). Duration of the
blood sampling procedure was also compared to the respective cortisol
level detected using the Pearson's correlation test. Signiﬁcance level for
all tests was set at p≤0.05.
3. Results
The marmosets' scan levels (Fig. 1) differed signiﬁcantly between
groups (duration: F1,104=48.95, pb0.001; frequency: F1,104=77.64,
pb0.001) and trials (duration: F12,104=2.23, pb0.05; frequency:
F12,104=3.26, pb0.001), with a signiﬁcant group vs. trial interaction
(duration: F12,104=2.19, pb0.05; frequency: F12,104=2.48, pb0.01).
Accordingly, scan duration and frequency on test trials 4 to 9 were
signiﬁcantly (pb0.05) higher than those observed on test trial 1, al-
beit only in the cocaine-treated marmosets. The scan-rates of this
group — from test trial 2 onward — differed signiﬁcantly (pb0.05)
from those of the saline-group. During the subsequent 4 withdrawal-
trials, scan duration and frequency did not differ signiﬁcantly between
cocaine- and saline-treated marmosets, with rates being constant and
similar to those seen during the test-trial 1. In the saline-group, scan-
behavior (duration and frequency) remained constant throughout the
entire procedure.
A similar proﬁle was seen in terms of the number of glances (Fig. 1),
with signiﬁcant differences between groups (F1,104=91.63, pb0.001)
and trials (F12,104=5.55, pb0.001), as well as a group vs. trial interac-
tion (F12,104=5.60, pb0.001). In fact, in the cocaine-treated subjects,
glance-frequency increased over the course of the test-trials, such that
test-trials 4 to 9 differed signiﬁcantly (pb0.05) not only from test-trial
1, but from the saline-treated group as well. During the subsequent
withdrawal-trials, this parameter remained at levels similar to those
of test-trial 1, in both cocaine- and saline-treated subjects. In the saline-
group, glance-frequency also remained constant over the course of the
entire procedure.
Contrary to the vigilance-related behaviors, the number of leg stands
decreased over the course of the study, regardless of the treatment given,
attaining a signiﬁcantly lower level during all 4 withdrawal trials com-
pared to test-trial 1 (group effect: F1,104=0.08, p>0.05; trial effect:
F12,104=1.87, pb0.05; interaction: F12,104=0.17, p=1.00; Fig. 1). For
the remaining behaviors scored — locomotor-related measures
(Table 1) — signiﬁcant between- and within-group effects were not
observed, as well as no group vs. trial interaction (Distance Traveled —
group effect: F1,104=0.13, p>0.05; trial effect: F12,104=0.84, p>0.05;
interaction: F12,104=0.54, p>0.05; Sections Crossed — group effect:F1,104=2.21, p>0.05; trial effect: F12,104=1.09, p>0.05; interaction:
F12,104=0.90, p>0.05; Average Speed — group effect: F1,104=0.28,
p>0.05; trial effect: F12,104=1.09, p>0.05; interaction: F12,104=0.74,
p>0.05).
The levels of circulating cortisol did not differ between groups or
samples (group: F1,39=0.19, p>0.05; sample: F4,39=0.24, p>0.05; in-
teraction: F4,39=0.22, p>0.05; Table 2). Cortisol levelswere also not sig-
niﬁcantly correlated with the time required to obtain the blood sample
(baseline: r=−0.11, p>0.05; post-test trial 1: r=−0.59, p>0.05;
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12 weeks post-extinction: r=−0.24, p>0.05).
4. Discussion
Marmosets repeatedly injected with cocaine (5 mg/kg) demonstrat-
ed, after a few trials, a signiﬁcant increase in vigilance-related behaviors,
with no concomitant alteration in their locomotor pattern or cortisol
level. In fact, from test trials 4 to 9, cocaine-treated subjects displayed sig-
niﬁcantly higher levels of scan (duration/frequency) and glance behav-
iors than when they were ﬁrst exposed to the psychostimulant (test
trial 1) and compared to marmosets that only received saline.
The gradual development of hypervigilance-related behaviors may
indicate a sensitization effect. During all four withdrawal trials, the
number of scans and glances made by the cocaine-treated subjects did
not differ signiﬁcantly from those of the saline-group and were similar
to the levels detected on their ﬁrst cocaine exposure. The sudden cessa-
tion of these behaviors during withdrawal does not indicate condition-
ing of the hypervigilance-related behaviors. Scanning was also recently
correlatedwith the neurochemical content in different areas of themar-
moset brain (de Souza Silva et al., 2007), pointing towards a possible
right hemispheric specialization for emotionally relevant stimuli. Re-
peated psychostimulant administration also led to a progressive in-
crease in visual monitoring of the surroundings in rhesus (e.g., Farfel
et al., 1992) and vervetmonkeys (e.g., Ridley et al., 1982),with paranoid
psychosis being reported inhumans (reviewed in Bradberry, 2007). Acute
or repeated cocaine injections do not typically modify vigilance-related
behaviors in rodents (Bradberry, 2007). On the other hand, and regardless
of the treatment, the number of leg-stands steadily decreased across tri-
als. This posture has been associated with an increased visibility of the
surroundings and interest in novel objects (Stevenson and Rylands,
1988),with different pharmacological treatmentsmodulating the num-
ber of leg stands in marmosets (e.g., Barros et al., 2007). However, the
proﬁle presently observed seemsmore akin to a habituation effect, sim-
ilar to previous reports by our group (e.g., Barros et al., 2004a).
Locomotion, measured as the number of sections crossed and the
distance and average speed traveledwithin the OF apparatus, remained
unaltered throughout the test trials, with saline- and cocaine-treated
subjects demonstrating similar levels. There was a tendency, however,
towards a decrease in locomotion over the course of the nine test trials.
Repeated exposure to novel environments, aswas the OF arena, typical-
ly decreases anxiety-induced locomotion in marmosets (Barros et al.,
2004a). Alternatively, dominance of the vigilance-related repertoire
may competitively suppress locomotor activity in this species (Barros
et al., 2004b). Accordingly, in the present study, a decline in locomotion
(regardless of the treatment administered) may be due to an envi-
ronmental habituation and/or behavioral competition effect. In ro-
dents, cocaine-induced hyperlocomotion is typically seen following
both acute and repeated injections, an effect not consistently dem-
onstrated in humans or NHP (Bradberry, 2007). De Souza Silva et
al. (2006a, 2006b) reported a locomotor effect after an acute injec-
tion of cocaine, but only in a subset of high-responder marmosets
and with a higher dose (10 mg/kg). In other NHP, psychostimulants
seem, at best, to idiosyncratically enhance motor stereotypies, suchTable 2
Serum levels of cortisol in saline- and cocaine-treated marmosets on each of the ﬁve
blood samples obtained during the course of the experimental procedure; mean±
SEM (μg/dL).
Blood sample Treatment-group
Saline Cocaine
Baseline 92±14 84±16
Post-test trial 1 102±7 94±8
Post-test trial 4 91±6 89±6
Post-extinction trial 4 102±10 91±8
12 weeks post-extinction 103±18 103±17as pacing and circling (e.g., Castner and Goldman-Rakic, 2003),
while naive human volunteers exhibit increased activity levels fol-
lowing limited amphetamine exposure (e.g., Strakowski and Sax,
1998).
In terms of the cortisol levels, repeated administrations of cocaine
and saline in themarmosets had no effect on the basal levels of this hor-
mone. Activation of the HPA axis is known to occur following acute co-
caine exposure, culminating in higher cortisol content in the blood
(Mello and Mendelson, 2002). In the present study, as we intended to
evaluate the effects of repeated cocaine treatment on basal cortisol
levels, there was a long interval between treatment administrations
and blood samplings (i.e., the next morning). Interestingly, Lima et al.
(2008) also reported a lack of effect on cortisol levels in marmosets,
having quantiﬁed this hormone immediately, 30 and 60 min after a
10 mg/kg dose of cocaine, with increases occurring only 60 min after
20 mg/kg. One may not exclude the possibility that the capture and an-
esthesia procedure may have incurred a ceiling effect, although previ-
ous studies have reported experimentally-induced increases in blood
cortisol levels beyond that seen in the present study (e.g. Norcross
and Newman, 1999). In fact, the present concentrations were similar
to those reported for marmosets (e.g., Boere et al., 2005) and not signif-
icantly correlated with the duration of the procedure, and the levels
detected in the saline-group remained constant even after repeated
samplings. The absence of an effect on basal cortisol concentrations
may be partly due to the callitrichid's (as well as other New World
primate's) low receptor binding afﬁnity, leading to high baseline glu-
cocorticoids levels (e.g., Chrousos et al., 1982; however see for
example Scammell et al., 2001). New World monkeys are somehow
resistant, however, to the typical deleterious effects of high basal
levels of glucocorticoids (hypercortisolemia), such as those seen in
Cushing's syndrome (e.g., rapid weight gain, hyperglycemia and hy-
pertension). In squirrel monkeys, another glucocorticoid-resistant
neotropical primate, cocaine priming reinstated drug-seeking, yet failed
to alter salivary cortisol (Lee et al., 2003; Platt et al., 2007), while
Tiefenbacher et al. (2003) required higher doses of CRF than ACTH to sig-
niﬁcantly increase salivary cortisol. In rhesus monkeys, cocaine-induced
release of cortisol is commonly reported (e.g., Broadbear et al., 1999),
suggesting that Old (including humans) and New World monkeys may
differ in this respect.
In summary, a low dose of cocaine repeatedly administered to
drug-naïve marmosets induced a slow-onset hypervigilance effect,
with no concomitant change in locomotion or cortisol level in this
glucocorticoid-resistant primate. Therefore, marmosets seem to have a
similar behavioral — but not hormonal — response as human and
other NHPs repeatedly injected with cocaine. Vigilance measures in
this and other NHPs may, thus, constitute unique markers to assess
cocaine-induce behavioral changes.Acknowledgements
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